Been watching! They have news Video Demonstration
Post# of 41
NEW YORK, Oct. 17, 2018 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today provided shareholders with a video demonstration on its website of the potential effectiveness of CBM BioPharma, Inc.'s ("CBM) innovative drug platform. As previously disclosed on October 11, 2018, Spherix entered into a merger agreement with CBM, a privately held innovative pharmaceutical company focused on the development of drugs in the multibillion-dollar oncology therapeutics market. The notable video, which was recorded at Wake Forest University, visually demonstrates the potential effectiveness of one of CBM's primary drug candidates known as KPC34. Researchers at Wake Forest have been testing whether KPC34 can be used on mouse subjects to treat Acute Lymphoblastic Leukemia (ALL) that has spread to the nervous system. Once recurrent ALL spreads to the nervous system, patients often experience paralysis.
NOTE : Fewer than 200,000 US cases per year
Acute lymphoblastic leukemia is the most common childhood cancer. It occurs when a bone marrow cell develops errors in its DNA.
Symptoms may include enlarged lymph nodes, bruising, fever, bone pain, bleeding from the gums, and frequent infections.
Treatments may include chemotherapy or targeted drugs that specifically kill cancer cells.
Yet nothing about Paralysis. Yet the video if accurate is awesome for the mouse. Yet it could have other usage that why they call it medical practice!
Dominari Holdings Inc. (DOMH) Stock Research Links
I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.